Protective role of polyphenols in cyclosporine A-induced nephrotoxicity during rat pregnancy

Journal of Histochemistry and Cytochemistry

Volumn 54, Issue 8, 2006, Pages 923-932

  Rezzani, Rita ^a   Rodella, Luigi Fabrizio ^a   Tengattini, Sandra ^a   Bonomini, Francesca ^a   Pechánová, Olga ^b   Kojšová, Stanislava ^b   Andriantsitohaina, Ramaroson ^c   Bianchi, Rossella ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

^c UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Cyclosporine A; Kidney; Polyphenols; Pregnancy

Indexed keywords

ANTIOXIDANT; CYCLOSPORIN A; GELATINASE A; INDUCIBLE NITRIC OXIDE SYNTHASE; MATRIX METALLOPROTEINASE; OLIVE OIL; POLYPHENOL; PROVINOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CELL PROTECTION; CONTROLLED STUDY; DRUG INDUCED DISEASE; FEMALE; IMMUNOHISTOCHEMISTRY; KIDNEY PARENCHYMA; MALE; MORPHOGENESIS; NEPHROTOXICITY; NEWBORN; NONHUMAN; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RENAL PROTECTION;

ANIMALS; ANIMALS, NEWBORN; ANTIOXIDANTS; BODY WEIGHT; CYCLOSPORINE; FEMALE; FLAVONOIDS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY DISEASES; KIDNEY GLOMERULUS; LITTER SIZE; MALE; MATERNAL-FETAL EXCHANGE; MATRIX METALLOPROTEINASE 2; MORPHOGENESIS; NITRIC OXIDE SYNTHASE TYPE II; PHENOLS; PREGNANCY; RATS; RATS, WISTAR;

ANIMALIA;

EID: 33746290183     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/jhc.6A6936.2006     Document Type: Article

References (36)

1. Armenti VT (2004) Immunosuppression and teratology: evolving guidelines. J Am Soc Nephrol 15:2759-2760
2. Balbi AP, Costa RS, Coimbra TM (2004) Postnatal renal development of rats from mothers that received increased sodium intake. Pediatr Nephrol 19:1212-1218
3. Bar Oz B, Hackman R, Einarson T, Koren G (2001) Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis. Transplantation 71:1051-1055
4. Bermas BL, Hill JA (1995) Effects of immunosuppressive drugs during pregnancy. Arthritis Rheum 38:1722-1732
5. Buffoli B, Pechánová O, Kojšová S, Andriantsitohaina R, Giugno L, Bianchi R, Rezzani R (2005) Provinol prevents CsA-induced nephrotoxicity by reducing reactive oxygen species, iNOS, and NF-kB expression. J Histochem Cytochem 53:1459-1468
6. Bush KT, Sakurai H, Tsukamoto T, Nigam SK (1999) Acute renal failure: cellular features of injury and repair. In Schreir RW, ed. Atlas of Diseases of the Kidney, Vol. 2. Oxford, Blackwell Science Ltd., 16.2-16.9
7. Durak İ, Özbek H, Elgün S (2004) Cyclosporine reduces hepatic antioxidant capacity: protective roles of antioxidants. Int Immunopharmacol 4:469-473
8. Eberhardt W, Beeg T, Beck KF, Walpen S, Gauer S, Bohles H, Pfeilschifter J (2000) Nitric oxide modulates expression of matrix metalloproteinase-9 in rat mesangial cells. Kidney Int 57:59-69
9. Fozza C, Dore F, Bonfigli S, Podda L, Longinotti M (2005) Two cases of chronic lymphoproliferative disorders in psoriatic patients treated with cyclosporine: hairy cell leukemia and Waldenstrom macroglobulinemia. Eur J Dermatol 15:271-273
10. Hong ME, Hong JC, Stepkowski S, Kahan BD (2005) Correlation between cyclosporine-induced nephrotoxicity in reduced nephron mass and expression of kidney injury molecule-1 and aquaporin-2 gene. Transplant Proc 37:4254-4258
11. Khanna AK, Hosenpud JS, Plummer MS, Hosenpud JD (2002) Analysis of transforming growth factor-β and profibrogenic molecules in a rat cardiac allograft model treated with cyclosporine. Transplantation 73:1543-1549
12. Knepper MA, Kim GH, Fernandez-Llama P, Ecelbarger CA (1999) Regulation of thick ascending limb transport by vasopressin. J Am Soc Nephrol 10:628-634
13. Lucas SRR, Silva VLC, Miraglia SM, Gill FZ (1997) Functional and morphometric evaluation of offspring kidney after intrauterine undernutrition. Pediatr Nephrol 11:719-723
14. Manach C, Mazur A, Scalbert A (2005) Polyphenols and prevention of cardiovascular diseases. Curr Opin Lipidol 16:77-84
15. Middleton E Jr, Kandaswami C, Theoharides TC (2000) The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52:673-751
16. Nishiyama A, Kobori H, Fukui T, Zhang GX, Yao L, Rahman M, Hitomi H, et al. (2003) Role of angiotensin E and reactive oxygen species in cyclosporine A-dependent hypertension. Hypertension 42:754-760
17. Nyberg G, Haljamäe U, Frisenette-Fich C, Wennergren M, Kjellmer I (1998) Breast-feeding during treatment with cyclosporine. Transplantation 65:253-255
18. Padgett EL, Seelig LL Jr (2002) Effects on T-cell maturation and proliferation induced by lactational transfer of cyclosporine to nursing pups. Transplantation 73:867-874
19. Papaccio G, Esposito V (1990) Ciclosporin administration during pregnancy induces ultrastructural changes on pancreatic beta-cells of newborn rats. Acta Anat (Basel) 137:336-341
20. Pereira LM, Querido DL, Madeira AC, Mandarim-De-Lacerda CA (2002) Volume-weighted mean glomerular volume in spontaneously hypertensive rats treated with different doses of spironolactone. Int Braz J Urol 28:356-362
21. Ponticelli C (2005) Cyclosporine: from renal transplantation to autoimmune disease. Ann NY Acad Sci 1051:551-558
22. Rawdanowicz TJ, Hampton AL, Nagase H, Woolley DE, Salamonsen LA (1994) Matrix metalloproteinase production by cultured human endometrial stromal cells: identification of interstitial collagenase, gelatinase-A, gelatinase-B, and stromelysin-1 and their differential regulation by interleukin-1 alpha and tumor necrosis factor-alpha. J Clin Endocrinol Metab 79:530-536
23. Redondo-Horcajo M, Lamas S (2005) Oxidative and nitrosative stress in kidney disease: a case for cyclosporine A. J Nephrol 18:453-457
24. Rezzani R (2004) Cyclosporine A and adverse effects on organs: histochemical studies. Prog Histochem Cytochem 39:85-128
25. Rezzani R, Rodella L, Bianchi R (1997) Cyclosporine and pregnancy in the rat. Transplantation 63:164-167
26. Rezzani R, Rodella L, Buffoli B, Goodman AA, Abraham NG, Lianos EA, Bianchi R (2005) Change in renal heme oxygenase expression in cyclosporine A-induced injury. J Histochem Cytochem 53:1459-1468
27. Rezzani R, Rodella L, Dessy C, Daneau G, Bianchi R, Feron O (2003) Changes in Hsp90 expression determine the effects of cyclosporine A on the NO pathway in rat myocardium. FEBS Lett 552:125-129
28. Rizzoni D, Rossi GP, Porteri E, Sticchi D, Rodella L, Rezzani R, Sleiman I, et al (2004) Bradykinin and matrix metalloproteinases are involved the structural alterations of rat small resistance arteries with inhibition of ACE and NEP. J Hypertens 22:759-766
29. Sanchez-Lozada LG, Tapia E, Johnson RJ, Rodriguez-Iturbe B, Herrera-Acosta J (2003) Glomerular hemodynamic changes associated with arteriolar lesions and tubulointerstitial inflammation. Kidney Int Suppl 86:59-14
30. Sgro MD, Barozzino T, Mirghani HM, Sermer M, Moscato L, Akoury H, Koren G, et al. (2002) Pregnancy outcome post renal transplantation. Teratology 65:5-9
31. Siwik DA, Colucci WS (2004) Regulation of matrix metalloproteinases by cytokines and reactive oxygen/nitrogen species in the myocardium. Heart Fail Rev 9:43-51
32. Tendron A, Decramer S, Justrabo E, Gouyon JB, Semama DS, Gilbert T (2003) Cyclosporin A administration during pregnancy induces a permanent nephron deficit in young rabbits. J Am Soc Nephrol 14:3188-3196
33. Tendron-Franzin A, Gouyon JB, Guignard JP, Decramer S, Justrabo E, Gilbert T, Semama DS (2004) Long-term effects of in utero exposure to cyclosporin A on renal function in the rabbit. J Am Soc Nephrol 15:2687-2693
34. van den Borne BE, Landewe RB, Houkes I, Schild F, van der Heyden PC, Hazes JM, Vandenbroucke JP, et al. (1998) No increased risk of malignancies and mortality in cyclosporin A-treated patients with rheumatoid arthritis. Arthritis Rheum 41:1930-1937
35. Venkataramanan R, Koneru B, Wang CC, Burckart GJ, Caritis SN, Starzl TE (1988) Cyclosporine and its metabolites in mother and baby. Transplantation 46:468-469
36. Williams D, Haragsim L (2006) Calcineurin nephrotoxicity. Adv Chronic Kidney Dis 13:47-55